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Abstract
T regulatory (Treg) cells expressing the transcription factor FoxP3 play a key role in protection against autoimmune disease.
GFP-FoxP3 reporter mice have been used widely to study the induction, function and stability of both thymically- and
peripherally-induced Treg cells. The N-terminal modification of FoxP3, however, affects its interaction with transcriptional
co-factors; this can alter Treg cell development and function in certain self-antigen specific animal models. Interestingly,
Treg cell function can be negatively or positively affected, depending on the nature of the model. In this study, we focused
on the effect of the GFP-FoxP3 reporter on Treg cell development and function in the Tg4 mouse model. In this model, T
cells express a transgenic T cell receptor (TCR) specific for the Myelin Basic Protein (MBP) peptide Ac1-9, making the animals
susceptible to experimental autoimmune encephalomyelitis (EAE), a disease akin to multiple sclerosis in humans. Unlike
diabetes-susceptible mice, Tg4 FoxP3gfp mice did not develop spontaneous autoimmune disease and did not demonstrate
augmented susceptibility to induced disease. Concurrently, thymic generation of natural Treg cells was not negatively
affected. The induction of FoxP3 expression in naive peripheral T cells was, however, significantly impaired as a result of the
transgene. This study shows that the requirements for the interaction of FoxP3 with co-factors, which governs its regulatory
ability, differ not only between natural and inducible Treg cells but also between animal models of diseases such as diabetes
and EAE.
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Introduction
T regulatory (Treg) cells expressing the transcription factor
FoxP3 play an indispensible role in the maintenance of peripheral
homeostasis and avoidance of autoimmune disease. Loss or
reduced function of FoxP3 leads to severe immunological disorders
characterized by lymphocyte hyperproliferation, organ infiltration
and autoimmune disease, both in man and mouse [1,2]. The
FoxP3tm2Ayr reporter allele [3], which encodes FoxP3 fused with
enhanced Green Fluorescence Protein (eGFP) at its N-terminus,
has been used widely to study the role of FoxP3 in a broad range
of settings. Two recent reports, however, suggest that this
modification of FoxP3 may alter its function in models of
autoimmune diabetes or arthritis [4,5]. Interestingly, both groups
found that diabetes onset and severity were exacerbated in NOD
mice carrying the GFP transgene, whereas Darce et al found
disease to be ameliorated in the K/BxN arthritis model. Although
FoxP3 is generally seen as the master regulator of Treg cell
function, it needs to interact with a host of co-factors (as many as
361) to exert its regulatory effect [6,7]. In the GFP-FoxP3 fusion
protein, the interaction of some of these factors with the N-
terminus of FoxP3 is abolished, whereas other interactions are
augmented [4,8]. This differential effect may account for the
distinct outcomes in the different disease models. For example,
altered IRF4 function may explain the difference between the T
helper 1 (Th1) cell-mediated disease in the diabetes model and the
Th2-dependent arthritis model [5].
In order to better understand the distinct effects of the N-
terminal modification of FoxP3 in different disease models, we
crossed Tg4 mice [9], which carry a transgenic T cell receptor
(TCR) specific for the myelin basic protein (MBP) peptide Ac1-9
(Ac-ASQKRPSQR), with FoxP3gfp (FoxP3tm2Ayr) C57BL/6 mice
to create Tg4 FoxP3gfp mice. Tg4 mice are susceptible to Th1-
initiated development of Experimental Autoimmune Encephalo-
myelitis EAE), a model for multiple sclerosis [10]. Spontaneous
autoimmune disease in Tg4 mice is controlled by functional
FoxP3+ Treg cells, as Rag-deficient Tg4 mice, which are naturally
devoid of Treg cells, develop encephalomyelitis at 11–12 weeks of
age [11]. In this study, we looked at both natural Treg (nTreg) cells
generated in the thymus upon recognition of self antigen and
inducible Treg (iTreg cells), which are generated from naive
conventional T (Tconv) cells in the periphery in the presence of
Transforming Growth Factor-b (TGF-b) (reviewed by Josefowicz
et al., [6]). Tg4 FoxP3gfp mice did not demonstrate an augmented
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susceptibility to autoimmune disease nor did they demonstrate
altered thymic generation of nTreg cells. In vitro differentiation of
iTreg cells was, however, impaired in cells expressing the GFP-
FoxP3 allele, particularly under conditions suboptimal for
induction.
Materials and Methods
Ethics statement
All experiments were carried out under a UK Home Office
Project License and were subject to assessment by the University of
Bristol ethical review committee.
Mice
C57BL/6 FoxP3tm2Ayr mice, created by the group of A.Y.
Rudensky [3], were crossed with CD45.2+ Tg4 mice [9] and
backcrossed 4 times to obtain the Tg4 FoxP3gfp strain. These, as
well as Tg4 CD45.1+, H2URagKO and B10.PL mice, were bred
under specific pathogen free conditions.
Peptides
The acetylated N-terminal peptide of murine MBP, Ac1-9 (Ac-
ASQKRPSQR) was custom synthesized (purity.85%; GL
Biochem (Shanghai) Ltd.).
T cell isolation
CD4+CD62L+ naive T cells were isolated magnetically from
splenocytes using a naive T cell isolation kit (Miltenyi Biotec)
according to the manufacturer’s recommendations.
Flow cytometry
Flow cytometric analysis was performed using an LSR II flow
cytometer (BD). Cell phenotypes were analyzed using combina-
tions of anti-GITR-PE, anti-PD-1-PE, anti-FoxP3-PE or -
efluor450, anti-CD25-PE or- PECy7, anti-CD45.2-PerCPCy5.5,
anti-Helios-AlexaFluor647, anti-CD103-APC, anti-CD8-APC,
anti-CD4-AlexaFluor700 (all from eBioscience), anti-CD45.1-
APC (BD bioscience) and CD103-PerCPCy5.5 (Biolegend) anti-
bodies. Fixable viability dye eFluor780 (eBioscience) was used in
all experiments to exclude dead cells. Results were analyzed using
FlowJo analysis software (Tree Star, Inc.).
iTreg cell generation
CD4+CD62L+ naive splenic T cells were cultured in vitro for 7
days in the presence of 100 U/ml rhIL-2 (R&D systems) and
10 ng/ml rhTGF-b1 (Peprotech). Cells were stimulated either with
anti-CD3e (1 mg/ml) and anti-CD28 (2 mg/ml) plate-bound
antibody (eBioscience) or MBP Ac1-9 peptide at 0.01 or 0.1 mg/
ml, in the presence of irradiated B10.PL splenocytes as antigen-
presenting cells. The level of FoxP3 induction was assessed by flow
cytometry prior to in vitro co-culture or transfer in vivo.
Proliferation/suppression assays
For in vitro experiments, both iTreg cells (CD45.2+) and naive
CD4+CD62L+ CD45.1+ T cells were labeled with 5 mM Cell
Proliferation Dye (CPD) eFluor450 (eBioscience). 56105 naive T
cells, together with the indicated ratio of iTreg cells, were
stimulated for 72 h with 10 mg/ml MBP Ac1-9 peptide in the
presence of 16106 irradiated B10.PL splenocytes serving as
antigen-presenting cells, in 48-well plates. For in vivo experiments,
CPD eFluor450 labeled CD45.1+ naive cells (males, 26106,
females 56106) and CD45.2+ iTreg cells were transferred
intraperitoneally to H2URagKO recipients. Cells were recovered
from the spleen on day 5 and proliferation as indicated by CPD
eFluor450 dilution was assessed by flow cytometry.
Induction and scoring of EAE
14–15 week-old mice were primed subcutaneously at the base of
the tail with 200 mg of MBP Ac1-9 in 0.1 ml of a sonicated
emulsion consisting of an equal volume of complete Freund’s
adjuvant (CFA) and PBS containing 4 mg/ml of heat-killed
Mycobacterium Tuberculosis (both from Difco). On days 0 and 2,
200 ng of Pertussis toxin (Sigma Aldrich) was administered
intraperitoneally in 0.5 ml of PBS. EAE was assessed twice daily
for 21 days with the following scoring system: 0, no signs; 1, flaccid
tail; 2; impaired righting reflex and/or gait; 3, hind limb paralysis;
4, forelimb and hind limb paralysis; 5, moribund.
Statistical analysis
Data was analyzed for statistical significance using GraphPad
Prism software.
Results
Modification of FoxP3 does not significantly alter the
number of nTreg cells
In order to study the effect of fusing GFP to the FoxP3 protein
on the generation of nTreg cells, we looked at the expression of
FoxP3 by CD4+ T cells in young Tg4 FoxP3wt and FoxP3gfp males
(5–7 weeks of age). The frequency of FoxP3 expression by
CD4+CD82 cells isolated from the thymus was identical regardless
of transgene expression (Figure 1A). In the spleen, the frequency of
FoxP3 expression by CD4+ T cells showed a trend towards lower
expression in mice carrying the GFP-FoxP3 transgene (Figure 1A),
yet the absolute number of CD4+FoxP3+ cells in the spleen did not
change significantly (Figure 1B). Next, we looked at FoxP3
expression in the mesenteric lymph nodes (mLN) as these are a
major site of peripheral FoxP3 induction [6]. Unlike the thymus,
the mLN showed a reduction in the frequency of FoxP3 expression
in CD4+ T cells from Tg4 FoxP3gfp mice, indicating that in the
periphery GFPpos Treg cells may demonstrate impaired prolifer-
ation, survival or induction (figure 1A). The average expression of
FoxP3 per cell (as determined by the Mean Fluorescence Index
(MFI) of anti-FoxP3 staining) in male Tg4 FoxP3wt and Tg4
FoxP3gfp animals did not vary as a result of the transgene, in any of
the organs examined (Figure 1C). The foxp3 gene is located on the
X chromosome; so, due to the process of X chromosome
inactivation, approximately half of Treg cells are expected to
express wild-type and half transgenic FoxP3 in heterozygous
females. Although the frequency of FoxP3 expression in the
thymus, spleen and mLN of Tg4 FoxP3wt/wt, FoxP3wt/gfp and
FoxP3gfp/gfp females (aged 5–8 weeks) did not differ with statistical
significance, a trend towards lower FoxP3 frequency in the mLN
was observed depending on the level of transgene expression
(Figure 1D).
GFPpos cells inTg4 FoxP3wt/gfp females demonstrate
greater expression of Treg cell functional antigens
X chromosome inactivation is generally considered to be a
random process. Therefore, in Tg4 FoxP3-GFPwt/gfp females,
50% of all CD4+FoxP3+ Treg cells were expected to be GFPpos
and 50% GFPneg. This, however, turned out not to be the case. As
shown in Figure 2A, the majority of animals (aged 5–8 weeks)
investigated demonstrated a higher than anticipated frequency of
GFPpos Treg cells in the thymus, spleen and mLN. Interestingly,
this result is the opposite of that reported in K/BxN, C57BL/6
FoxP3 Modification Impairs iTreg Cell Generation
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and NOD mice, where the frequency of GFPpos Treg cells in
FoxP3wt/gfp females was generally lower than 50% [5].
In the next step, we examined the expression of antigens
commonly associated with Treg cell function and Treg cell
subtypes to try and establish whether both GFPneg and GFPpos
Treg cells in Tg4 FoxP3wt/gfp females are genuine and functional
suppressor cells. Helios is an Ikaros-family transcription factor
predominantly expressed in FoxP3+ Treg cells. It has been
Figure 1. Young Tg4 FoxP3gfpmice have unaltered levels of FoxP3 expression. A. FoxP3 expression by CD4+CD82 thymocytes or CD4+ cells
from the spleen and mesenteric lymph nodes of male Tg4 FoxP3wt and Tg4 FoxP3gfp mice aged 5–7 weeks, directly ex vivo. Horizontal bar indicates
mean. * p = 0.0329, ** p = 0.0084, n.s. = not significant. 2-tailed, unpaired student’s t test, n = 7 each. B. Total number of splenocytes, CD4+ T cells and
FoxP3+CD4+ Treg cells in the spleen of male Tg4 mice aged 5–7 weeks. Data displayed as mean, error bar indicates SEM. n= 3 each, * p = 0.0108,
n.s. = not significant. 2-tailed, unpaired student’s t test. C. Mean fluorescence intensity of FoxP3 staining in Treg cells in the thymus, spleen and mLN
of 5–7 week old male Tg4 mice. Data displayed as mean, error bar indicates SEM. n= 3 each, no statistical difference, unpaired, 2-tailed student’s t
test. D. Frequency of FoxP3 expression on CD4+CD82 thymocytes or CD4+ cells from the spleen or mLN of Tg4 FoxP3wt/wt, Tg4 FoxP3wt/gfp or Tg4
FoxP3gfp/gfp females aged 5–8 weeks. FoxP3wt/wt n = 8, FoxP3wt/gfp n = 12, FoxP3gfp/gfp n = 4. No statistically significant differences, Tukey’s multiple
comparison test.
doi:10.1371/journal.pone.0061334.g001
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suggested that Helios can be used to distinguish nTreg cells from
iTreg cells; however, this theory has been challenged, including in
the Tg4 model [12,13,14]. Here, we found a greater percentage of
Helios expressing cells among GFPpos Treg cells than GFPneg Treg
cells in Tg4 FoxP3wt/gfp females (Figure 2B). The glucocorticoid-
induced TNF receptor (GITR) has been suggested to be a more
accurate marker for Treg cells than CD25 as it is also expressed on
CD252FoxP3+ cells with regulatory function [15]. It was found to
be expressed on all FoxP3+ Treg cells in Tg4 FoxP3wt/gfp mice,
regardless of GFP expression (Figure 2C). CD103, an a/b integrin
that may identify a more potent subpopulation of Treg cells [16],
showed a higher frequency of expression on GFPpos than GFPneg
Treg cells in our model (Figure 2D). Similarly, the negative co-
stimulatory molecule Programmed Death-1 (PD-1), which affects
both the generation and function of Treg cells [17], was also more
commonly expressed on GFPpos than GFPneg Treg cells, although
the difference was less striking than found for CD103 or Helios
(Figure 2E). The classic Treg cell identifier CD25 was expressed
highly on both GFPneg and GFPpos FoxP3+ Treg cells, with a small
increase in the latter (Figure 2F). Considering that most of these
Treg cell markers are also indicators of T cell activation, we
examined the expression of CD62L, a selectin commonly
associated with naive T cells, and Ki67, a nuclear protein present
in dividing but not resting T cells, to establish whether there might
Figure 2. GFPpos Treg cells display a potentially more suppressive phenotype in Tg4 FoxP3wt/gfp females. A. Representative dot plot
(splenocytes, left) and distribution graph (right) showing the frequency of GFP expression in CD4+FoxP3+ cells from the thymus, spleen and mLN of
Tg4 FoxP3wt/gfp females aged 5–8 weeks. Horizontal dotted line represents the predicted frequency. P values show significance of actual vs predicted
value. 2-tailed, paired student’s t test. n = 10 each. B-H. Representative, smoothed, cytometry plots and distribution graphs showing the frequency of
marker expression on GFPpos and GFPneg splenic CD4+FoxP3+ Treg cells in Tg4 FoxP3wt/gfp females aged 5–10 weeks. P values represent significance
determined by 2-tailed, unpaired student’s t test. n.s. = not significant. B. Helios, n = 10. C. GITR, n = 10. D. CD103, n = 10. E. PD-1, n = 10. F. CD25, n = 6.
G. CD62L, n = 4. H. Ki67, n = 4.
doi:10.1371/journal.pone.0061334.g002
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be a difference in the activation status of GFPneg and GFPpos Treg
cells in Tg4 FoxP3wt/gfp females. The expression of CD62L was
not significantly different between GFPneg and GFPpos Treg cells
(Figure 2G). Ki67 expression was slightly elevated in GFPpos Treg
cells (Figure 2H), but mean expression was much higher in both
GFPneg Treg cells (25.1860.74%) and GFPpos Treg cells
(30.8561.55%) than in CD4+ Tconv cells of the same mice
(7.1160.34%, data not shown). The slight increase in Ki67
expression but similar CD62L expression may suggest augmented
homeostatic turnover of GFPpos Treg cells, yet this is not reflected
in the frequency of GFPpos Treg cells in the periphery versus the
thymus (Figure 2A). In conclusion, the phenotype of GFPpos Treg
cells in Tg4 FoxP3wt/gfp females, suggests they may be more potent
immune regulators than their wild-type counterparts.
Aged Tg4 FoxP3gfp mice harbor lower peripheral Treg
cell numbers but do not develop spontaneous
autoimmune disease
Tg4 mice are susceptible to induced EAE but do not develop
disease spontaneously. To determine whether the modification of
FoxP3 would increase susceptibility to spontaneous autoimmune
disease, despite the lack of obvious detrimental alterations to their
Treg cells as described above, we followed groups of Tg4 FoxP3wt
and Tg4 FoxP3gfp males until 16–24 weeks of age. Tg4 Rag2/2
mice, which are naturally devoid of Treg cells, develop sponta-
neous CNS autoimmune disease at 11–12 weeks of age [11]. Tg4
FoxP3gfp mice, however, did not demonstrate any sign of disease
even at 24 weeks of age (data not shown), thus indicating that
immune regulation in these animals was not severely impaired.
However, in contrast to younger mice, both the frequency and the
absolute number of FoxP3+ Treg cells in the spleen of aged males
were significantly lower in Tg4 FoxP3gfp compared to Tg4
FoxP3wt individuals (Figure 3A and 3B). This seemed to have
resulted from a greater expansion or peripheral induction of
FoxP3+ Treg cells in the Tg4 FoxP3wt mice, rather than a loss of
expression in the Tg4 FoxP3gfp mice, as the latter had the same
number of FoxP3+ cells in the spleen at 16–24 weeks as at age 5–7
weeks (Figures 1B and 3B). Although differences were small, Treg
cells in older Tg4 FoxP3gfp males demonstrated elevated levels of
Helios, but lower levels of PD-1 expression than in Tg4 FoxP3wt
mice (Figure 3A). The mean level of FoxP3 expression per Treg
cell (as determined by MFI) was only moderately lower in Tg4
FoxP3wt than Tg4 FoxP3gfp animals at age 16–24 weeks
(Figure 3C). In the mLN, a similar difference in the frequency of
FoxP3 expression as in the spleen was found between Tg4 FoxP3wt
and Tg4 FoxP3gfp mice (Figure 3D). Finally, the frequency of
CD44hi memory CD4+ Tconv cells was low and comparable
between the two groups, supporting the notion that despite the
lack of peripheral Treg cell accumulation, Tg4 FoxP3gfp mice were
not more susceptible to spontaneous activation of self-reactive T
cells and subsequent autoimmune disease (Figure 3E).
In vitro generation of iTreg cells is impaired in Tg4
FoxP3gfp naive CD4+ cells
The lower number of peripheral FoxP3+ Treg cells in aged Tg4
FoxP3gfp males suggests that either peripheral induction, survival
or expansion of Treg cells is negatively affected by the transgene.
The finding that a greater fraction of splenic GFPpos than GFPneg
Treg cells in Tg4 FoxP3wt/gfp females express the indicator of cell
division Ki67 (Figure 2H) suggested peripheral expansion was not
impaired as a result of the transgene. Therefore, we studied the in
vitro induction of FoxP3 expression in naive CD4+CD62L+ splenic
T cells under the influence of IL-2 and TGF-b1. We compared
iTreg cell generation using either a combination of plate-bound
anti-CD3 and anti-CD28 or cognate MBP Ac1-9 peptide
presented by irradiated APC as a stimulus, as previous findings
had suggested that the resulting cells may have different
characteristics [13]. In males, the percentage of FoxP3 induction
was markedly decreased in Tg4 FoxP3gfp CD4+ T cells compared
to Tg4 FoxP3wt CD4+ T cells, either using different concentrations
of peptide or antibody stimulation (Figure 4A). Furthermore,
unlike what we observed in nTreg cells, Tg4 FoxP3gfp iTreg cells
showed a lower level of FoxP3 expression (MFI) than Tg4 FoxP3wt
iTreg cells (Figure 4B). A similar effect was observed in Tg4
FoxP3wt/wt versus Tg4 FoxP3wt/gfp females, albeit less distinct, as
expected, because only a fraction of Treg cells carried the
transgene in heterozygous mice (Figure 4C). Remarkably,
although the GFP-FoxP3 transgene clearly impaired iTreg cell
generation, the frequency of GFPpos cells among Tg4 FoxP3wt/gfp
iTreg cells was still higher on average than the 50% expected in
the case of random X chromosome inactivation (Figure 4D). The
relative expression of GFP in FoxP3+ iTreg cells generated from
Tg4 FoxP3wt/gfp naive CD4+ splenocytes seemed to correlate with
the success of FoxP3 induction in general, as the method that gave
the highest level of FoxP3 expression, i.e. antibody stimulation
which gave around 95% FoxP3 induction, also gave the highest
percentage of GFPpos FoxP3+ iTreg cells. In these antibody-
generated Tg4 FoxP3wt/gfp iTreg cells in particular, the frequency
of GFPpos cells showed a strong correlation with the frequency of
GFPpos cells in thymic nTreg cells of the same mouse (Figure 4E).
This would indicate that the frequency at which GFPpos iTreg or
nTreg cells are generated in Tg4 FoxP3wt/gfp mice depends not
only the efficacy of their induction, but is determined largely prior
to FoxP3 expression, either in the thymus or periphery. This
could, for example, result from non-random X chromosome
inactivation, where either the wild-type or transgenic allele is
preferentially silenced. To further support the notion that the
frequency of GFPpos cells among FoxP3wt/gfp iTreg cells generated
using antibody stimulation of naive T cells was predetermined
mostly by a genetic factor rather than a result of a functional
difference between GFPneg and GFPpos iTreg cells during
differentiation, we studied the rate at which female Tg4
FoxP3wt/gfp CD4+ T cells divided during the seven-day in vitro
culture. Naive T cells were labeled with Cell Proliferation Dye
(CPD)-eFluor450 prior to stimulation with plate-bound anti-CD3
and anti-CD28 antibody in the presence of IL-2 and TGF-b1. As
shown in Figure 4F, GFPneg and GFPpos iTreg cells proliferated at
the same rate during differentiation. This was confirmed in TG4
FoxP3wt/gfp females with both a high (top row) or low (bottom row)
frequency of GFPpos Treg cells.
Finally, we assessed phenotypic differences between GFPneg and
GFPpos iTreg cells generated from naive Tg4FoxP3wt/gfp CD4+
splenocytes, either using cognate peptide or plate-bound antibody.
Expression of the Helios transcription factor was much higher in
peptide-generated than antibody-generated iTreg cells from Tg4
FoxP3wt/gfp females, as expected from previous results [13], with
the frequency of Helios expression dependent on the concentra-
tion of peptide used (Figure 4H, top row). GFPpos iTreg cells
showed a moderately higher frequency of Helios expression than
GFPneg iTreg cells regardless of the induction method. PD-1
expression showed a pattern opposite to that of Helios expression,
with the highest frequency found in antibody-generated iTreg cells
and a higher percentages in GFPneg than GFPpos iTreg cells
(Figure 4H, bottom row). These findings suggest that the lower
number of FoxP3+ cells found in the spleen of aged Tg4 FoxP3gfp
males reflects an impaired peripheral generation of FoxP3+ iTreg
cells as a result of the transgene. The GFP-FoxP3 fusion seemed
FoxP3 Modification Impairs iTreg Cell Generation
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particularly detrimental to FoxP3 induction under conditions of
suboptimal iTreg cell generation with peptide, which may be the
more physiologically relevant method.
Tg4 FoxP3gfp and Tg4 FoxP3wt iTreg cells are unstable, in
vitro and in vivo
To examine whether not only the degree of FoxP3 induction
and expression of Treg-associated antigens, but also the function-
ality of FoxP3-GFPpos iTreg cells was altered, we tested their
stability and suppressive ability both in vitro and in vivo. Although
iTreg cells are commonly seen as a prime therapeutic target for the
induction of immune tolerance, the stability of their phenotype, in
particular, raises concerns [18]. For these experiments, antibody-
induced iTreg cells were used as these could be generated to a very
high level of purity (approximately 95% in Tg4 FoxP3wt cells) with
only a marginal reduction in FoxP3 expression (2–3%) in Tg4
FoxP3gfp cells. First, we looked at the ability of male CD45.2+ Tg4
FoxP3wt and Tg4 FoxP3gfp iTreg cells to suppress the peptide-
induced activation of naive CD4+CD62L+ Tg4 CD45.1+ T cells in
vitro. Both iTreg cells and naive Tconv cells were labeled with
CPD-eFluor450 to monitor expansion. Tg4 FoxP3wt and Tg4
FoxP3gfp iTreg cells both significantly reduced the proliferation of
the Tconv cells at high ratios, although Tg4 FoxP3gfp iTreg cells
were the more effective suppressors (Figure 5A and 5B). However,
the Tg4 FoxP3gfp iTreg cells were also of a less stable phenotype,
with around 2/3 of iTreg cells losing Foxp3 expression after 3 days
(Figure 5C). We next examined iTreg cells generated from naive
Tg4 FoxP3wt/gfp female CD4+ T cells in order to compare the
stability of FoxP3 expression in GFPpos and GFPneg iTreg cells in
the same culture. In this case, the stability of FoxP3+ cells
depended on the ratio of iTreg cells to naive CD4+ T cells in the
culture, with the higher ratio giving greater stability (Figure 5D
and 5E). The frequency of GFPpos cells among iTreg cells that had
retained FoxP3 expression was only fractionally lower compared
to that before culture, indicating that the difference in stability of
GFPpos and GFPneg iTreg cells is limited in co-culture. iTreg cells
from Tg4 FoxP3wt/gfp females were similarly suppressive to those
from Tg4 FoxP3wt/wt mice (Figure 5F).
Figure 3. Lower number of peripheral FoxP3+ Treg cells in aged Tg4 FoxP3gfp males. A. Frequency of FoxP3 expressing CD4+ T cells in the
spleen of Tg4 FoxP3wt and Tg4 FoxP3gfp males aged 16–24 weeks (left) and the frequency of Helios and PD-1 expression gated on CD4+FoxP3+
splenocytes (middle and right). FoxP3wt n = 9, FoxP3gfp n = 6. Data represented as individual scores, with mean6SEM. B. Total number of splenocytes,
CD4+ T cells or CD4+FoxP3+ Treg cells in the spleen. FoxP3wt n= 9, FoxP3gfp n = 6. Data represented as mean + SEM. C. Mean fluorescence intensity of
FoxP3 staining in Treg cells in the spleen. FoxP3wt, n = 9, FoxP3gfp n = 6. Data represented as mean+SEM. D. Frequency of Foxp3 expression by CD4+
cells in the mLN. FoxP3wt n = 4, FoxP3gfp n = 3. Data represented as individual scores, with mean6SEM. E. Percentage of CD44hi CD4+ T cells in the
spleen. FoxP3wt n = 9, FoxP3gfp n = 6. Data represented as individual scores, with mean6SEM. P values represent significance determined by 2-tailed,
unpaired student’s t test. n.s. = not significant.
doi:10.1371/journal.pone.0061334.g003
FoxP3 Modification Impairs iTreg Cell Generation
PLOS ONE | www.plosone.org 6 April 2013 | Volume 8 | Issue 4 | e61334
Figure 4. Impaired FoxP3 induction in naive Tg4 FoxP3gfp CD4+ T cells. A. In vitro FoxP3 induction in male, naive CD4+CD62L+ T cells by
stimulation with peptide and antigen-presenting cells or plate-bound anti-CD3 and anti-CD28 antibody in the presence of IL-2 and TGF-b1 for 7 days.
n = 6 each for peptide stimulation, n = 8 each for antibody stimulation. B. Mean fluorescence intensity of anti-FoxP3 antibody staining in FoxP3+ iTreg
cells. Data represented as mean + SEM. n = 6 each for peptide stimulation, n = 8 each for antibody stimulation. C. In vitro FoxP3 induction in female
Tg4 FoxP3wt/wt and Tg4 FoxP3wt/gfp naive CD4+ T cells. Peptide stimulation; FoxP3wt/wt n = 5, FoxP3wt/gfp n = 8. Antibody stimulation; FoxP3wt/wt
n = 10, FoxP3wt/gfp n = 9. D. Frequency of GFP expression in FoxP3+CD4+ iTreg cells generated from Tg4 FoxP3wt/gfp naive T cells using peptide or
plate-bound antibody. Peptide stimulation; n = 8, antibody stimulation; n = 10. E. Correlation plot of the frequency of GFP expression in antibody-
induced FoxP3+ iTreg cells and thymic FoxP3+ nTreg cells from the same female Tg4 FoxP3wt/gfp mice. n = 11. F. Proliferation of CD4+ T cells during
antibody-mediated iTreg cell generation. Naive female CD4+CD62L+ Tg4 FoxP3wt/gfp cells were labeled with 5 mM CPD-eFluor450 prior to 7-day
culture with IL-2 and TGF-b1. Plots gated on FoxP3
+ Treg cells. Shown are proliferation of GFPneg and GFPpos Treg cells from mice with a high (top
row) or low (bottom row) frequency of GFP expression. Histogram overlays show proliferation of GFPneg (black, open line) and GFPpos (grey, filled line)
Treg cells. 2 out of 4 identical experiments (each in triplicate) shown. G. Frequency of Helios and PD-1 expression in GFPpos and GFPneg FoxP3+CD4+
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iTreg cells generated from splenic, naive CD4+ T cells of Tg4 FoxP3wt/gfp mice. n = 8. A, B and C; 2-tailed, unpaired student’s t test. D. 2-tailed, paired t
test on actual measurements versus predicted value of 50%. F and G; 2-tailed, paired student’s t test.
doi:10.1371/journal.pone.0061334.g004
Figure 5. Tg4 FoxP3gfp iTreg cells are suppressive but unstable in vitro. A. Representative histograms of cell proliferation dye dilution in
labeled CD45.1+ naive CD4+ T cells cultured for 3 days with/without Tg4 FoxP3wt or Tg4 FoxP3gfp iTreg cells at a 1:1 or 2:1 ratio and stimulated with
10 mg/ml MBP Ac1-9. One representative of three identical experiments in triplicate. B. Proliferation index of naive CD4+ cells after 72 h co-culture
with/without iTreg cells. Means of 3 identical experiments carried out in triplicate. * p , 0.05, ** p , 0.001, Tukey’s multiple comparison test. C.
Frequency of FoxP3 expression and proliferation of CD45.2+ iTreg cells after 3-day co-culture with naive CD45.1+ CD4+ T cells. One experiment
representative of three carried out in triplicate. Gated on live CD45.2+ CD4+ T cells. D. Purity of FoxP3+ CD4+CD25+ Tg4 FoxP3wt/gfp iTreg cells and
frequency of GFP expression therein, prior to in vitro co-culture with naive T cells. E. Proliferation and FoxP3 retention of CD45.2+ Tg4 FoxP3wt/gfp
iTreg cells as well as frequency of GFP expression among CD45.2+ FoxP3+ cells after 3-day co-culture with naive CD45.1+ CD4+ T cells. F. CD25
expression and cell proliferation dye dilution in naive CD45.1+ CD4+ T cells after 72-h in vitro co-culture with CD45.2+ Tg4 FoxP3wt/wt or Tg4
FoxP3wt/gfp iTreg cells at different ratios. Proliferation dye dilution displayed as dot plot versus CD25 expression, or off-set histogram overlays. D-F.
One experiment representative of 3 identical experiments.
doi:10.1371/journal.pone.0061334.g005
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Considering the unstable phenotype of iTreg cells in these in
vitro cultures, it is not unreasonable that the suppressive effect on
the proliferation of Tconv cells was, at least in part, due to nutrient
depletion in the culture rather than a direct suppressive effect. To
address this, we investigated the ability of CD45.2+ Tg4 FoxP3gfp
iTreg cells to limit homeostatic expansion of CD45.1+
CD4+CD62L+ naive Tconv cells upon transfer to lymphopenic
H2URagKO mice. These experiments demonstrated that neither
male Tg4 FoxP3wt and Tg4 FoxP3gfpiTreg cells nor female Tg4
FoxP3wt/gfp iTreg cells had a significant effect on naive T cell
expansion in this setting (Figure 6A and 6B). Interestingly though,
Foxp3 expression in Tg4 FoxP3wt/gfp iTreg cells showed a very
similar level of stability in vivo as observed in vitro, with
approximately half the cells having lost FoxP3 expression 5 days
post transfer (Figure 6C and 6D). Furthermore, the frequency of
GFPpos cells among iTreg cells that had retained FoxP3 expression
after transfer was only moderately reduced, confirming that the
phenotype of GFPpos iTreg cells was not much less stable than that
of GFPneg iTreg cells when transferred together (Figure 6D).
Tg4 FoxP3gfp mice do not show augmented
susceptibility to induced CNS autoimmune disease
Although Tg4 FoxP3gfp mice do not show an increase in the
incidence of spontaneous autoimmune disease, the impaired
generation of iTreg cells that results from the modification of
FoxP3 raised the question whether they display augmented
susceptibility to induced EAE. To address this, we immunized
both male and female mice (average age of 14-15 weeks) with
MBP Ac1-9 peptide in complete Freund’s adjuvant (Figure 7 A-C).
It was clear from these experiments that neither Tg4 FoxP3gfp
males nor Tg4 FoxP3gfp/gfp females demonstrated exacerbated
disease compared to wild-type controls. In fact, the disease
incidence in both males and females suggested that the GFP-
FoxP3 transgene may have provided enhanced protection,
although the difference was not as profound as previously reported
for spontaneous disease in the K/BxN arthritis model [5].
Overall, we conclude that the modification of FoxP3 in this
model selectively affects the peripheral induction of FoxP3
expression, with thymic generation of MBP-specific nTreg cells
seemingly unimpaired. The reduced peripheral induction of
FoxP3+ Treg cells does not hinder the protection against
spontaneous or provoked encephalomyelitis in the Tg4 mouse,
suggesting that thymic nTreg cells provide an important barrier to
the development of this autoimmune disease.
Discussion
Treg cells expressing the FoxP3 transcription factor play a
crucial role in the protection against undesired T cell activation
and autoimmune disease, while still allowing a fast and effective
immunological response to pathogens. To exert its role, FoxP3
interacts with an astonishing array of transcriptional regulators [7].
The complexity of this network makes predicting the effect of any
mutation in the FoxP3 protein a daunting task. In this study, we
found that the number of nTreg cells generated in the thymus of
Tg4 FoxP3gfp mice was not altered significantly, but lower
numbers of FoxP3+ Treg cells in peripheral lymphoid organs of
mature mice first suggested that iTreg cell development was
impaired as a result of the N-terminal modification of FoxP3. This
Figure 6. Tg4 iTreg cells are unstable during homeostatic expansion in vivo. A. Representative histogram overlay of cell proliferation dye
dilution of labeled male Tg4 CD45.1+ CD4+ Tconv cells (left) and proliferation index (mean6SEM), 5 days after co-transfer with/without CD45.2+ Tg4
FoxP3wt or Tg4 FoxP3gfp iTreg cells into lymphopenic H2URagKO mice. One representative of three identical experiments. B. Representative
histogram overlay of cell proliferation dye dilution in labeled female Tg4 CD45.1+ CD4+ Tconv cells (left) and proliferation index (mean6SEM), 5 days
after co-transfer with/without CD45.2+ Tg4 FoxP3wt/gfp iTreg cells into lymphopenic H2URagKO mice. One representative of three identical
experiments. C. Purity of FoxP3+ CD4+CD25+ Tg4 FoxP3wt/gfp iTreg cells and frequency of GFP expression therein, prior to co-transfer with naive T
cells. D. Proliferation and FoxP3 retention of CD45.2+ Tg4 FoxP3wt/gfp iTreg cells (left) as well as frequency of GFP expression among CD45.2+ FoxP3+
cells (right), 5 days after co-transfer with naive CD45.1+ CD4+ Tconv cells. C and D; One experiment representative of 3 identical experiments.
doi:10.1371/journal.pone.0061334.g006
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impaired iTreg cell differentiation was confirmed in vitro, but
interestingly, in female Tg4 FoxP3wt/gfp mice, we found that the
mean frequency of GFPpos cells among Treg cells in the thymus
and periphery was not only often higher than the 50% expected
from random X chromosome inactivation, it was also much higher
than previously demonstrated in FoxP3-reporter K/BxN, NOD
and C57BL/6 mice [5]. This could suggest that the nature of the
MBP Ac1-9 peptide, for which T cells in the Tg4 model express a
specific TCR, or other strain-specific characteristics somehow give
GFPpos cells a selective advantage during thymic generation.
However, this does not explain the observation of the very strong
correlation in GFP expression between thymic nTreg cells and
iTreg cells generated in vitro from splenic naive CD4+ T cells of
the same Tg4 FoxP3wt/gfp female. The correlation would suggest
that the skewed frequency at which the GFP-carrying X
chromosome is active is determined prior to FoxP3 induction
and maintained during both thymic and peripheral Treg cell
development. In fact, X chromosome inactivation in mice may not
be random but rather be partially imprinted [19]. This would
imply that the maternal X chromosome has a slight advantage
over the paternal one, thus skewing the frequency of active X-
chromosomal genes in heterozygous animals. In our Tg4
FoxP3wt/gfp females, where the GFP-encoding X chromosome
was generally maternal, this would mean that the results were
geared towards a higher frequency of GFPpos Treg cells, as found.
In theory, the difference between our results and those of others
may, therefore, not reflect a difference in Treg development
between the models but rather a difference in breeding strategy to
obtain heterozygous females.
Based on their own findings, Darce et al suggested that the
modification of FoxP3 leads to a stronger suppression of Th2 and
Th17 cell-mediated arthritis, whereas protection against Th1 cell-
linked diabetes is negatively affected due to the enhanced
interaction of IRF4 with mutated FoxP3 [5]. In the Tg4 mouse,
encephalomyelitis is initiated by Th1 cells but may also have
elements of Th17 cell responses, although the latter are not strictly
required for pathology [10]. It was, therefore, interesting to find
that Tg4 FoxP3gfp mice did not develop spontaneous EAE, did not
Figure 7. Tg4 FoxP3gfp mice are not more susceptible to induced disease. A. Mean EAE disease scores (6 SEM) in male and female Tg4
FoxP3 mice, after induction of disease with MBP Ac1-9 in CFA. Male Tg4 FoxP3wt n= 7, male Tg4 FoxP3gfp n = 10, female Tg4 FoxP3wt/wt n = 6, female
Tg4 FoxP3wt/gfp n = 7, female Tg4 FoxP3gfp/gfp n = 4. B. Mean percentage of initial body weight (on day -1)6SEM, after disease induction. C. disease
incidence, mean day of onset (6 SD), mean maximum disease grade (6 SD) and mortality during the first 21 days following disease induction.
doi:10.1371/journal.pone.0061334.g007
FoxP3 Modification Impairs iTreg Cell Generation
PLOS ONE | www.plosone.org 10 April 2013 | Volume 8 | Issue 4 | e61334
show augmented peripheral lymphocyte activation or hyperpro-
liferation even at 24 weeks of age, and showed no greater
susceptibility to induced EAE. Moreover, the phenotype of GFPpos
nTreg cells suggested that they may have augmented suppressive
abilities compared to GFPneg nTreg cells in Tg4 FoxP3wt/gfp mice,
based on increased expression of common Treg cell markers such
as CD103 and PD-1. This, surprisingly, phenotypically links the
Tg4 model of EAE more to the K/BxN model of Th2/Th17-
mediated arthritis than the NOD model of Th1-mediated
diabetes.
The lack of increase in Foxp3+ Treg cell number in the spleens
of aged Tg4 FoxP3gfp males compared to younger equivalents
suggested that peripheral induction of FoxP3 expression may be
impaired. Indeed, both the use of peptide and antibody
stimulation to generate iTreg cells, in vitro, demonstrated that
the frequency of Foxp3 induction was negatively affected by the
transgene. This was particularly apparent at peptide concentra-
tions that yielded a lower conversion rate of Tconv cells to iTreg
cells. Importantly, GFPpos iTreg cells also showed a lower level of
FoxP3 expression per cell, which may compromise their stability,
as FoxP3 stabilizes its own transcription [20]. This was reflected in
the stability of Tg4 FoxP3gfp iTreg cells in co-culture with Tconv
cells but not to the same level in conditions using Tg4 FoxP3wt/gfp
iTreg cells. In the latter case, the GFPneg iTreg cells may have
aided the stability of GFPpos iTreg cells.
Overall, we demonstrate here that the N-terminal modification
of FoxP3 impairs the generation of peripheral iTreg cells but not
thymic nTreg cells in the Tg4 model. The latter seem equally or
more functional than their wild-type counterparts and successfully
protect against autoimmune disease. In the Tg4 FoxP3gfp mouse,
T cells express a TCR specific for a thymically expressed protein,
which may explain why tolerance can be maintained by functional
nTreg cells, even when peripheral conversion of autoreactive T
cells to a suppressor phenotype is clearly impaired. Finally, these
results indicate that the complexity of interactions of FoxP3 with
other transcriptional regulators is such that seemingly unobtrusive
mutations or polymorphisms may have dramatic and unpredict-
able effects, depending on the context.
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